BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30488206)

  • 1. Expression of Genes Encoding Cell Motility Proteins during Progression of Head and Neck Squamous Cell Carcinoma.
    Kakurina GV; Kondakova IV; Spirina LV; Kolegova ES; Shashova EE; Cheremisina OV; Novikov VA; Choinzonov EL
    Bull Exp Biol Med; 2018 Dec; 166(2):250-252. PubMed ID: 30488206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the Levels of mRNA Expression for Protein Phosphatase 1B and Proteins Involved in Cytoskeleton Remodeling in Squamous Cell Carcinoma of the Larynx and Hypopharynx.
    Kakurina GV; Kolegova ES; Shashova EE; Velikaya VV; Startseva ZA; Cheremisina OV; Choinzonov EL; Kondakova IV
    Bull Exp Biol Med; 2020 Aug; 169(4):504-507. PubMed ID: 32915364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of cytoskeleton remodeling proteins and their mRNA expression in tumor tissue of metastatic laryngeal and hypopharyngeal cancers.
    Kakurina GV; Cheremisina OV; Sereda EE; Kolegova ES; Kondakova IV; Choinzonov EL
    Mol Biol Rep; 2021 Jun; 48(6):5135-5142. PubMed ID: 34231097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.
    Ingruber J; Savic D; Steinbichler TB; Sprung S; Fleischer F; Glueckert R; Schweigl G; Skvortsova II; Riechelmann H; Dudás J
    Cells; 2021 Mar; 10(3):. PubMed ID: 33802627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of mRNA Expression Levels of LRP1 and Actin-Binding Proteins with the Development of Laryngeal and Laryngopharyngeal Squamous Cell Carcinoma.
    Kakurina GV; Kolegova ЕS; Shashova ЕЕ; Velikaya VV; Startseva ZА; Cheremisina ОV; Kondakova IV; Choinzonov ЕL
    Bull Exp Biol Med; 2020 Oct; 169(6):802-805. PubMed ID: 33108559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
    Wang L; Jia Y; Jiang Z; Gao W; Wang B
    Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway.
    Xu Q; Ma H; Chang H; Feng Z; Zhang C; Yang X
    Cell Death Dis; 2020 May; 11(5):405. PubMed ID: 32471980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
    Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
    Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
    J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
    Xue K; Li J; Nan S; Zhao X; Xu C
    Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma.
    Guo E; Mao X; Wang X; Guo L; An C; Zhang C; Song K; Wang G; Duan C; Zhang X; Yang X; Yuan Z; Sun J; Li X; Yang W; Meng H; Miao S
    Cell Death Dis; 2021 Aug; 12(8):764. PubMed ID: 34344861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of intracellular proteolysis with CAP1 and cofilin1 in non-small-cell lung cancer.
    Kolegova ES; Kakurina GV; Shashova EE; Yunusova NV; Spirina LV; Sidenko EA; Kostromitskiy DN; Dobrodeev AY; Kondakova IV
    J Biosci; 2021; 46():. PubMed ID: 34148878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
    Wu ZH; Fang M; Zhou Y
    PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
    Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
    Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program.
    Zhang M; Hoyle RG; Ma Z; Sun B; Cai W; Cai H; Xie N; Zhang Y; Hou J; Liu X; Chen D; Kellogg GE; Harada H; Sun Y; Wang C; Li J
    Mol Ther; 2021 Aug; 29(8):2583-2600. PubMed ID: 33794365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The
    Fukusumi T; Guo TW; Sakai A; Ando M; Ren S; Haft S; Liu C; Amornphimoltham P; Gutkind JS; Califano JA
    Clin Cancer Res; 2018 Feb; 24(3):619-633. PubMed ID: 29146722
    [No Abstract]   [Full Text] [Related]  

  • 19. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.